SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001485003-16-000101
Filing Date
2016-06-10
Accepted
2016-06-10 16:23:55
Documents
1
Period of Report
2016-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146559022241672.html 4  
1 FORM 4 wf-form4_146559022241672.xml 4 4131
  Complete submission text file 0001485003-16-000101.txt   5541
Mailing Address C/O ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142
Business Address
BERRY DAVID A (Reporting) CIK: 0001204876 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 161708922

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations